109 related articles for article (PubMed ID: 23558990)
21. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting.
Li X; Adam G; Cui H; Sandstedt B; Ohlsson R; Ekström TJ
Oncogene; 1995 Jul; 11(2):221-9. PubMed ID: 7624139
[TBL] [Abstract][Full Text] [Related]
22. High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19.
Douc-Rasy S; Barrois M; Fogel S; Ahomadegbe JC; Stéhelin D; Coll J; Riou G
Oncogene; 1996 Jan; 12(2):423-30. PubMed ID: 8570220
[TBL] [Abstract][Full Text] [Related]
23. Post-weaning diet affects genomic imprinting at the insulin-like growth factor 2 (Igf2) locus.
Waterland RA; Lin JR; Smith CA; Jirtle RL
Hum Mol Genet; 2006 Mar; 15(5):705-16. PubMed ID: 16421170
[TBL] [Abstract][Full Text] [Related]
24. Loss of imprinting in hepatoblastoma.
Rainier S; Dobry CJ; Feinberg AP
Cancer Res; 1995 May; 55(9):1836-8. PubMed ID: 7728748
[TBL] [Abstract][Full Text] [Related]
25. Temporal stability and age-related prevalence of loss of imprinting of the insulin-like growth factor-2 gene.
Cruz-Correa M; Zhao R; Oviedo M; Bernabe RD; Lacourt M; Cardona A; Lopez-Enriquez R; Wexner S; Cuffari C; Hylind L; Platz E; Cui H; Feinberg AP; Giardiello FM
Epigenetics; 2009 Feb; 4(2):114-8. PubMed ID: 19242102
[TBL] [Abstract][Full Text] [Related]
26. Analysis of IGF2 gene imprinting in breast and colorectal cancer by allele specific-PCR.
Yun K; Soejima H; Merrie AE; McCall JL; Reeve AE
J Pathol; 1999 Apr; 187(5):518-22. PubMed ID: 10398115
[TBL] [Abstract][Full Text] [Related]
27. Loss of imprinting of the insulin-like growth factor 2 and the H19 gene in testicular seminomas detected by real-time PCR approach.
Stier S; Neuhaus T; Albers P; Wernert N; Grünewald E; Forkert R; Vetter H; Ko Y
Arch Toxicol; 2006 Oct; 80(10):713-8. PubMed ID: 16721595
[TBL] [Abstract][Full Text] [Related]
28. Genomic imprinting of H19 and insulin-like growth factor-2 in pediatric germ cell tumors.
Ross JA; Schmidt PT; Perentesis JP; Davies SM
Cancer; 1999 Mar; 85(6):1389-94. PubMed ID: 10189147
[TBL] [Abstract][Full Text] [Related]
29. IGF2 but not H19 shows loss of imprinting in human glioma.
Uyeno S; Aoki Y; Nata M; Sagisaka K; Kayama T; Yoshimoto T; Ono T
Cancer Res; 1996 Dec; 56(23):5356-9. PubMed ID: 8968084
[TBL] [Abstract][Full Text] [Related]
30. Relaxation of imprinting of human insulin-like growth factor II gene, IGF2, in sporadic breast carcinomas.
Wu HK; Squire JA; Catzavelos CG; Weksberg R
Biochem Biophys Res Commun; 1997 Jun; 235(1):123-9. PubMed ID: 9196048
[TBL] [Abstract][Full Text] [Related]
31. Loss of imprinting in IGF2 in colorectal carcinoma assessed by microdissection.
Maenaka S; Hikichi T; Imai MA; Minamoto T; Kawahara E
Oncol Rep; 2006 Apr; 15(4):791-5. PubMed ID: 16525660
[TBL] [Abstract][Full Text] [Related]
32. Loss of imprinting of insulin growth factor II gene: a potential heritable biomarker for colon neoplasia predisposition.
Cruz-Correa M; Cui H; Giardiello FM; Powe NR; Hylind L; Robinson A; Hutcheon DF; Kafonek DR; Brandenburg S; Wu Y; He X; Feinberg AP
Gastroenterology; 2004 Apr; 126(4):964-70. PubMed ID: 15057734
[TBL] [Abstract][Full Text] [Related]
33. Analysis of genomic imprinting of insulin-like growth factor 2 in colorectal cancer.
Takano Y; Shiota G; Kawasaki H
Oncology; 2000 Sep; 59(3):210-6. PubMed ID: 11053988
[TBL] [Abstract][Full Text] [Related]
34. Expression of the imprinted IGF2 and H19 genes in the endometrium of cases with unexplained infertility.
Korucuoglu U; Biri AA; Konac E; Alp E; Onen IH; Ilhan MN; Turkyilmaz E; Erdem A; Erdem M; Menevse S
Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):77-81. PubMed ID: 20042264
[TBL] [Abstract][Full Text] [Related]
35. Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer.
Murphy SK; Huang Z; Wen Y; Spillman MA; Whitaker RS; Simel LR; Nichols TD; Marks JR; Berchuck A
Mol Cancer Res; 2006 Apr; 4(4):283-92. PubMed ID: 16603642
[TBL] [Abstract][Full Text] [Related]
36. Frequency and timing of loss of imprinting at 11p13 and 11p15 in Wilms' tumor development.
Brown KW; Power F; Moore B; Charles AK; Malik KT
Mol Cancer Res; 2008 Jul; 6(7):1114-23. PubMed ID: 18644976
[TBL] [Abstract][Full Text] [Related]
37. Loss of imprinting and promoter usage of the IGF2 in laryngeal squamous cell carcinoma.
Grbesa I; Ivkic M; Pegan B; Gall-Troselj K
Cancer Lett; 2006 Jul; 238(2):224-9. PubMed ID: 16111804
[TBL] [Abstract][Full Text] [Related]
38. Relaxation of IGF2 imprinting in Wilms tumours associated with specific changes in IGF2 methylation.
Sullivan MJ; Taniguchi T; Jhee A; Kerr N; Reeve AE
Oncogene; 1999 Dec; 18(52):7527-34. PubMed ID: 10602511
[TBL] [Abstract][Full Text] [Related]
39. Hypomethylation of the P3 promoter is associated with up-regulation of IGF2 expression in human osteosarcoma.
Li Y; Meng G; Huang L; Guo QN
Hum Pathol; 2009 Oct; 40(10):1441-7. PubMed ID: 19427670
[TBL] [Abstract][Full Text] [Related]
40. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour.
Steenman MJ; Rainier S; Dobry CJ; Grundy P; Horon IL; Feinberg AP
Nat Genet; 1994 Jul; 7(3):433-9. PubMed ID: 7920665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
